1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
654BBBEA7E87DA8F000258589004E7B11
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-best-practices-distributing-medical-info-physicians-investigators-through-portals-other-means?opendocument
18
19opendocument
203.228.8.80
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Communication

Best Practices in Distributing Medical Info to Investigators and Physicians through Investigator Portals and Other Means

ID: 5618


Features:

2 Info Graphics

10 Data Graphics

70+ Metrics


Pages/Slides: 20


Published: 2020


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Best Practices in Distributing Medical Info to Investigators and Physicians through Investigator Portals and Other Means”

STUDY OVERVIEW

Medical Information groups play an important role in disseminating vital and diverse information to key external stakeholders such as investigators and physicians. To improve consistency and efficiency in meeting the informational needs of these stakeholders, Medical Information groups need to prioritize the type of information to be shared and the medium of communication.

Best Practices, LLC conducted this benchmarking research to examine how pharma companies distribute medical information to investigators and physicians. This study also highlights the usage of specific investigator websites and types of content shared by companies via this medium, protection of such websites, and tools used to access trial data, publications, abstracts, etc.


KEY TOPICS

  • Sharing of Clinical Information with Investigators
  • Access to Investigator Website Portal
  • Communication via Investigator Website Portal

KEY METRICS
  • How do you share clinical development publications, abstracts, etc. with your investigators?
  • What channels do you use to share information with your investigators?
  • What content is available on your investigator website?
  • Is your website/portal password protected to ensure that only investigator or physicians gain access?
  • Do different users have access to different types of content?
  • Does your investigator website include functionality that enables you (manufacturer) to communicate directly with investigators?

SAMPLE KEY FINDINGS
  • IST and clinical trial info shared via website: Companies with websites share more of IST and clinical trial content and less of current/past Congresses.

METHODOLOGY

Best Practices, LLC engaged 24 leaders from 19 pharmaceutical companies in this research through a benchmarking survey. Three-fourths of the study participants serve at the director level and above.


Industries Profiled:
Pharmaceutical; Biotech; Biopharmaceutical; Medical Device; Health Care; Clinical Research; Laboratories


Companies Profiled:
AbbVie; Allergan; Alnylam Pharmaceuticals; Boehringer Ingelheim; Clovis Oncology; CSL Behring; Dermira; Dova Pharmaceuticals; Edwards Lifesciences; Gilead Sciences; Ipsen; Lexicon Pharmaceuticals; Merck; Mylan; Novartis; Sanofi Genzyme; Sanofi; Sage Therapeutics; Vifor Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.